AE Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$25.8M Buy
63,647
+2,702
+4% +$1.1M 0.19% 121
2025
Q1
$30.3M Buy
60,945
+956
+2% +$476K 0.26% 93
2024
Q4
$31.2M Buy
59,989
+4,426
+8% +$2.3M 0.26% 90
2024
Q3
$34.4M Buy
55,563
+6,006
+12% +$3.72M 0.31% 81
2024
Q2
$27.4M Buy
49,557
+5,247
+12% +$2.9M 0.27% 85
2024
Q1
$25.8M Sell
44,310
-313
-0.7% -$182K 0.29% 86
2023
Q4
$24.4M Buy
44,623
+10,336
+30% +$5.66M 0.12% 186
2023
Q3
$17.4M Buy
34,287
+1,841
+6% +$932K 0.1% 213
2023
Q2
$16.9M Buy
32,446
+9,725
+43% +$5.07M 0.1% 237
2023
Q1
$13.1M Sell
22,721
-1,777
-7% -$1.02M 0.08% 285
2022
Q4
$13.5M Sell
24,498
-1,131
-4% -$623K 0.1% 245
2022
Q3
$13M Buy
25,629
+7,925
+45% +$4.02M 0.1% 206
2022
Q2
$9.62M Buy
17,704
+2,423
+16% +$1.32M 0.08% 280
2022
Q1
$9.03M Buy
15,281
+1,057
+7% +$624K 0.06% 307
2021
Q4
$9.49M Buy
14,224
+1,330
+10% +$887K 0.07% 274
2021
Q3
$7.37M Sell
12,894
-1,822
-12% -$1.04M 0.06% 291
2021
Q2
$7.42M Sell
14,716
-6,258
-30% -$3.16M 0.06% 275
2021
Q1
$9.57M Buy
20,974
+2,883
+16% +$1.32M 0.1% 211
2020
Q4
$8.43M Sell
18,091
-298
-2% -$139K 0.1% 206
2020
Q3
$8.12M Buy
18,389
+5,998
+48% +$2.65M 0.12% 164
2020
Q2
$4.49M Buy
12,391
+7,505
+154% +$2.72M 0.07% 235
2020
Q1
$1.39M Buy
4,886
+573
+13% +$163K 0.03% 403
2019
Q4
$1.4M Buy
4,313
+419
+11% +$136K 0.03% 449
2019
Q3
$1.13M Buy
3,894
+732
+23% +$213K 0.03% 417
2019
Q2
$929K Buy
3,162
+1,695
+116% +$498K 0.03% 423
2019
Q1
$402K Buy
1,467
+317
+28% +$86.9K 0.03% 395
2018
Q4
$257K Buy
1,150
+178
+18% +$39.8K 0.04% 388
2018
Q3
$237K Buy
+972
New +$237K 0.01% 513